HMGB1 and chronic obstructive pulmonary disease: It is possible that the trafficking of HMGB1, and other lung-derived DAMPs may be responsible for heightened extra-pulmonary inflammation that manifest in COPD patients presenting with ventricular dysfunction, myocardial infarction, diabetes or hypertension39,40.